This article was originally published in The Rose Sheet
Men's skin care line launching in September is expected to account for 5% of Clarins' sales rather than provide firm with 5% in incremental sales as reported in 1"The Rose Sheet" Aug. 19, 2002, p. 8...
You may also be interested in...
Clarins will promote the launch of its first men's skin care line with more than 400,000 samples at launch, VP-Marketing Caroline Pieper-Vogt said
US Regulatory Roundup, June 2020: FDA Talks QSR Redo; ISO Risk Standard Gets Companion Doc; Experts Predict Recalls Surge; And More
News out of the US FDA on the harmonization of its Quality System Regulation with ISO 13485, as well as stories on a new ISO technical report on risk management and a warning from experts about probable recalls because of the COVID-19 pandemic, were of most interest to our readers last month. Here are June’s 10 most popular US regulation and policy stories from Medtech Insight.
The Bayesian adaptive trial design helped slash the Phase I time for Ridgeback’s drug, which could provide a pill-based alternative to Gilead’s remdesivir for COVID-19 patients.